Drug Combo for Common Neuroendocrine Tumor: A New Standard? ...Middle East

Medscape - News
Drug Combo for Common Neuroendocrine Tumor: A New Standard?
Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients with gastroenteropancreatic neuroendocrine tumors, a phase 3 trial found. Medscape Medical News

Hence then, the article about drug combo for common neuroendocrine tumor a new standard was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Drug Combo for Common Neuroendocrine Tumor: A New Standard? )

Apple Storegoogle play

Last updated :

Also on site :



Latest News